Vanguard Personalized Indexing Management
XERS icon

Vanguard Personalized Indexing Management’s Xeris Biopharma Holdings XERS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.7K Buy
+11,073
New +$70.7K ﹤0.01% 2072
2025
Q4 		– Sell
-15,561
Closed -$127K – 2084
2025
Q3 		$127K Buy
+15,561
New +$103K ﹤0.01% 1783

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Personalized Indexing Management's XERS Position: Q2 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 11,073 shares worth $87.7K. The stake represents ﹤0.01% of the portfolio and ranks #2072 among its holdings. This is a return to the name: Vanguard Personalized Indexing Management previously reported a position in XERS as recently as Q3 2025.

Vanguard Personalized Indexing Management first reported a position in XERS in Q3 2025 and has held it in 2 quarters since. The position peaked at $127K in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Vanguard Personalized Indexing Management held 11,073 shares of Xeris Biopharma Holdings worth $87.7K as of Q2 2026.
  • Xeris Biopharma Holdings was a new Vanguard Personalized Indexing Management position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2072 holding.
  • Vanguard Personalized Indexing Management first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 2 quarters since.
  • Vanguard Personalized Indexing Management's Xeris Biopharma Holdings position peaked at $127K in Q3 2025.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.